Journal of Vascular and Interventional Radiology
Volume 19, Issue 2 , Pages 169-176 , February 2008

Does Percutaneous Transluminal Angioplasty Improve Quality of Life?

  • Aoife N. Keeling, FFRRCSI, MRCPI, MSc

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Peter A. Naughton, FRCSI

      Affiliations

    • Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.
    • ,
  • AnnaMarie O’Connell, FFRRCSI, MRCPI, MSc

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Michael J. Lee, FFRRCSI, FRCR, MSc

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • Corresponding Author InformationAddress correspondence to M.J.L., Radiology Department, Beaumont Hospital, Dublin 9, Ireland

Received 17 November 2006 ,Revised 18 July 2007 ,Accepted 17 September 2007.

References 

  1. Fowkes FGR, Housley E, Cawood EHH, MacIntyree CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384–392
  2. Bainton D, Sweetnam P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J. 1994;72:128–132
  3. Smith WCS, Woodward M, Tunstall-Pedoe H. Intermittent claudication in Scotland. In:  Fowkes FGR editors. Epidemiology of peripheral vascular disease. London: Springer-Verlag; 1991;p. 117–124
  4. Second European Consensus Document on Chronic Critical Limb Ischaemia. Circulation. 1991;84(suppl 3):1–26
  5. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026–3049
  6. Selvin E, Erlinger TP. Prevalence and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition examination survey, 1999–2000. Circulation. 2004;110:738–743
  7. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg. 1996;12:167–172
  8. Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? (Preliminary results from a prospective randomised trial). Eur J Vasc Surg. 1990;4:135–140
  9. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? (A randomized controlled trial). J Vasc Surg. 1997;26:551–557
  10. Perkins JMT, Collin J, Creasy TS, Fletcher EWL, Morris PJ. Exercise training versus angioplasty for stable claudication (Long and medium term results of a prospective, randomised trial). Eur J Vasc Endovasc Surg. 1996;11:409–413
  11. Chong PFS, Golledge J, Greenhalgh RM, Davies AH. Exercise therapy or angioplasty? (A summation analysis). Eur J Vasc Endovasc Surg. 2000;20:4–12
  12. Wolf GL, Wilson SE, Cross AP, Deupree RH, Stason WB. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial (Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199). J Vasc Interv Radiol. 1993;4:639–648
  13. Jackson MJ, Wolfe JH. Are infra-inguinal angioplasty and surgery comparable?. Acta Chir Belg. 2001;101:6–10
  14. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease: a decision and cost- effectiveness analysis. JAMA. 1995;274:165–171
  15. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. Br Med J. 2002;324:1417–1421
  16. Hunink MGM, Meyerovitz MF. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med. 1992;326:414
  17. Testa MA, Lenderking WR. Interpreting pharmacoeconomic and quality of life clinical trial data for use in therapeutics. Pharmacoeconomics. 1992;2:107–117
  18. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg. 1995;10:356–361
  19. Chetter IC, Spark JI, Kent PJ, Berridge DC, Scott DJA, Kester RC. Percutaneous transluminal angioplasty for intermittent claudication: Evidence on which to base the medicine. Eur J Vasc Endovasc Surg. 1998;16:477–484
  20. Pell JP, Lee AJ. Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants (The Scottish Vascular Audit Group). Scott Med J. 1997;42:47–48
  21. Bosch JL, van der Graaf Y, Hunink MGM. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease. Circulation. 1999;99:3155–3160
  22. Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg. 1988;2:283–291
  23. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996;11:65–69
  24. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36) I (Conceptual framework and item selection). Med Care. 1992;30:473–483
  25. Blake C, Codd MB, O’Meara YM. The short form 36 (SF-36) health survey: normative data for the Irish population. Ir J Med Sci. 2000;169:195–200
  26. Ware JE. SF-36 health survey manual and interpretation guide. Boston MA: Nimrod Press; 1993;
  27. Kalman PG, Johnston KW, Sniderman KW. Indications and results of balloon angioplasty for arterial occlusive lesions. World J Surg. 1996;20:630–634
  28. Matsi PJ, Manninem HI, Soder HK, Mustonen P, Kouri J. Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques. Clin Radiol. 1995;50:237–244
  29. Bradbury AW, Ruckley CV. Angioplasty for lower limb ischaemia: time for randomised controlled trials. Lancet. 1996;347:277–278
  30. Patrick DL, Bush JW, Chen MM. Toward an operational definition of health. J Health Soc Behav. 1973;14:6–23
  31. Brook RH, Ware JE, Rogers WH, et al. Does free care improve adults’ health? (Results from a randomized controlled trial). N Engl J Med. 1983;309:1426–1434
  32. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996;334:835–840
  33. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. JAMA. 1989;262:907–913
  34. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J. 1992;305:160–164
  35. Garratt AM, Ruta DA, Abdalla MI, Buckingham K, Russell IT. The SF-36 health survey questionnaire: an outcome measure suitable for routine use in the NHS?. BMJ. 1993;306:1440–1444
  36. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) (III: tests of data quality, scaling assumptions and reliability across diverse patient groups). Med Care. 1994;32:40–66
  37. Hemingway H, Stafford M, Stansfield S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? (Results from the Whitehall II study). Br Med J. 1997;315:1273–1279
  38. Chetter IC, Spark JI, Dolan P, Scott DJA, Kester RC. Quality of life analysis in patients with lower limb ischaemia; suggestions for European standardisation. Eur J Vasc Endovasc Surg. 1997;13:597–604
  39. Kind P, Carr-Hill R. The Nottingham health profile: a useful tool for epidemiologists?. Soc Sci Med. 1987;25:905–910
  40. Spronk S, Bosch JL, Veen HF, den Hoed PT, Hunink MGM. Intermittent claudication: functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty—systematic review. Radiology. 2005;235:833–842
  41. Feringa HH, Van Waning VH, Bax JJ, et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol. 2006;47:1182–1187
  42. Goldhaber SZ, Manson JE, Stampfer MJ, et al. Low-dose aspirin and subsequent peripheral arterial surgery in the Physician’s Health Study. Lancet. 1992;340:143–145
  43. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425–428
  44. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology. 2002;225:21–26
  45. Fabry R, Dubost JJ, Pochon P, Duchene-Marullaz P. Comparison of standard one- minute treadmill exercise and Strandness test (absolute walking distance) in relation to site of lesion, walking distance and diastolic blood flow velocity (Doppler curves). Angiology. 1990;41:869–876
  46. Abando A, Akopian G, Katz SG. Patient sex and success of peripheral percutaneous transluminal angioplasty. Arch Surg. 2005;140:757–761
  47. Kugler CFA, Rudofsky G. Do age and comorbidity affect quality of life or PTA- induced quality of life improvements in patients with symptomatic PAD?. J Endovasc Ther. 2005;12:387–393

 None of the authors have identified a conflict of interest.

PII: S1051-0443(07)01261-4

doi: 10.1016/j.jvir.2007.09.003

Journal of Vascular and Interventional Radiology
Volume 19, Issue 2 , Pages 169-176 , February 2008

Article Tools

* Image Usage & Resolution